Climate Change Data

Environmental Metrics

ESG Focus Areas

• Climate Change
• Water Management
• Air Quality
• Waste Management
• Biodiversity
• Sustainable Technology Development

Environmental Achievements

• Not disclosed

Social Achievements

• Not disclosed

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Reducing water consumption
• Reducing carbon emissions
• Reducing waste
• Minimizing impact on biodiversity

Mitigation Strategies

• Implementing water conservation measures and leak detection
• Assessing and reducing carbon footprint across scopes 1, 2, and 3
• Waste sorting and proper disposal, waste reduction efforts
• Attentiveness to biodiversity preservation and implementation of positive actions

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Supplier Code of Conduct

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Development of more sustainable technologies

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• SDG 6 (Clean Water and Sanitation)
• SDG 7 (Affordable and Clean Energy)
• SDG 11 (Sustainable Cities and Communities)
• SDG 13 (Climate Action)

MedinCell's commitment to reducing environmental impact aligns with these SDGs.

Sustainable Products & Innovation

• Long-acting injectable technology

Awards & Recognition

• Not disclosed

Environmental Metrics

ESG Focus Areas

• Good Health & Well-being
• Gender Equality
• Partnerships for the Goals
• Clean Water & Sanitation
• Product Quality & Safety
• Technological Innovation
• Access to Medicine
• Value Creation aligned with SDGs
• Retain and Develop Talents
• Employee Health and Safety
• Diversity, Inclusion & Gender Equality
• Carbon Footprint
• Resources Management
• Pollution & Biodiversity
• Business Ethics
• Good Governance and Legal Compliance

Environmental Achievements

• Reduced water consumption by 13%
• Upgraded electricity supply contract to a 100% renewable energy mix (post-closing)
• Overall volume of waste decreased slightly (15%)
• Use of the electric vehicle avoided the generation of 0.941 t of CO2e for a total of 3,113 km of travel
• Klaxit application lists 15,000 km saved by carpooling and the corresponding carbon footprint of 1.694 t CO2e

Social Achievements

• 92% of employees held shares in the Company, and 98% benefited from share grants
• Successfully integrated a worker with a motor disability into its workforce
• Reduced the average pay gap between men and women
• Achieved a score of 91/100 for the professional equality index
• High return-to-work and job retention rates for women after parental leave

Governance Achievements

• Established an ESG Committee
• Implemented an Anti-Corruption Policy and a Conflicts of Interest Policy
• Implemented a reporting system open to people outside the Company

Climate Goals & Targets

Environmental Challenges

• Risks associated with manufacturing and supplying a high-quality product
• Risks of long-term adverse reactions not detected, off-label use or questionable benefits
• Risks of being limited by the technological platform to develop certain treatments
• Risks related to the implementation of certain access-to-medicines strategies
• Risks of inadequate pricing in relation to product benefits
• Risks of limiting the financial value created by the financial risks associated with pharmaceutical development activities
• Risks related to technological limitations and intellectual property management
• Risks associated with insufficient value creation and sharing
• Risks linked to the difficulty of attracting and retaining talented employees
• Risks linked to deteriorating working conditions
• Risks related to the employer brand; risks related to the lack of value creation
• Risks related to a lack of environmental management
• Risks of worsening phenomena linked to climate change
• Risks associated with the water-intensive pharmaceutical industry
• Risks of poor environmental mismanagement of raw material resources
• Risks of environmental degradation in certain supply chain regions
• Risks associated with the possibility that, for certain products, the technology may not reduce the impact of pharmaceutical compounds
• Risk of environmental degradation
• Risks of non-compliance with the internal Code of Conduct, conflicts of interest, corruption, and human rights incidents
• Risks of aggressive commercial practices
• Risks of Medincell's lack of control and limited influence over its value chain

Mitigation Strategies

• Create safe, high-performance, high-quality technologies and products (QHSE policy)
• Maintain efficient internal quality assurance and compliance with best practices (GxP)
• Supporting innovation to better meet patient needs
• Couple our innovative technologies with a "Global Access" strategy
• Develop a virtuous company model based on the fair sharing of the value created
• Improve the efficiency of drugs and their therapeutic impact
• Being an attractive employer and fostering human development
• Promote employee health and well-being (QHSE policy, QLWC)
• Guarantee equal opportunities and equal treatment
• Minimize our carbon footprint
• Offer products with reduced environmental impact
• Develop technologies compatible with sustainable resources management
• Working with partners who share our values
• Ensure good corporate governance (Middle Next Code)
• Ensure legal compliance

Supply Chain Management

Supplier Audits: 11 audits/year

Responsible Procurement

• Supplier Code of Conduct
• ESG questionnaire for high-stakes subcontractors

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: GRI, MiddleNext Code

Certifications: Null

Third-party Assurance: Becouze (COFRAC-accredited)

UN Sustainable Development Goals

• 1, 3, 5, 6, 8, 9, 12, 13, 16, 17

Medincell's products and activities contribute to these SDGs through improved access to healthcare, sustainable technologies, and ethical business practices.

Sustainable Products & Innovation

• UZEDY®, mdc-TJK, mdc-WWM, mdc-STM, mdc-CWM

Awards & Recognition

• Not disclosed